The first VR application to blend physical and cognitive fitness offers three activities for senior living communities to boost socialization and improve overall health amongst residents
LAS VEGAS, Jan. 03, 2022 (GLOBE NEWSWIRE) — Rendever, the leading virtual reality (VR) company created to assist seniors in overcoming social isolation through shared experiences, announces today that the interdisciplinary VR fitness platform, RendeverFit™, is now shipping globally. RendeverFit™, which first became available for preorders in September 2021, is the first VR application to blend physical and cognitive fitness for seniors while also boosting socialization.
“As the shift towards holistic health continues, we need to remember that products should be both accessible and enjoyable! When we started exploring the fitness landscape, it was clear that older adults haven’t had access to products accommodating their mobility needs that also drive motivation to engage and exercise. We’ve taken the strong social backbone that’s defined our platform ecosystem since 2016 to now provide a new form of fitness for older adults with RendeverFit™, one that will motivate a healthier lifestyle through shared experiences,” said Kyle Rand, Cofounder and CEO of Rendever. “Research shows that physical activity among seniors can delay the onset of dementia and also reduce the risk of cardiovascular disease, stroke and diabetes. By working with senior living communities and hospice care providers, seniors who physically can no longer take walks or ride a bike now have an alternate, social experience that will keep them moving – and smiling.”
Social engagement has been shown to improve mental health as well as emotional, psychological, and cognitive function among older adults. RendeverFit™ was designed to make physical activity engaging and fun for residents in senior living communities, improving overall health along the way.
“Rolling out RendeverFit™ to our residents is going to positively impact the overall happiness and health of our community. Residents always love trying something new to stay engaged and active, and RendeverFit™ is a platform we know they’ll want to use regularly,” said Kristen Pearce, Vice President of Social Services and Behavioral Health at Monarch Healthcare Management. “Our hope is that RendeverFit™ will bring our residents together while promoting a healthy lifestyle within our community.”
RendeverFit™ offers three modules within the platform, including:
Cycle: This activity offers participants the chance to cycle through beautiful landscapes with their friends as they reach out, pop colored balloons, and compete for high scores.
Paddle: In this activity, participants work on their hand-eye coordination as they develop their swing through target practice on a remote island.
Paint: Participants are invited to a creative immersive environment where they can move around their virtual canvas while painting in 3D. This module is an extension of MultiBrush, the first available multiplayer version of Tilt Brush that the company released in February 2021.
As each of the modules includes interactive hand games, Rendever chose Pico Interactive’s Neo 3 Pro as its hardware of choice. The Neo 3 Pro headsets offer improved accuracy with its 6DoF room-scale tracking. The headsets are lightweight with its ergonomic counterweight design, making it an ideal choice for seniors.
“With our Neo 3 Pro headsets for the enterprise, we continue to develop new features to support our wide range of platforms. One unique feature we’ve been developing is our hand tracking. It will make it possible for users to have more control over their hand movements, which is especially important in activities like those developed for RendeverFit™,” said Leland Hedges, General Manager of Pico Interactive in Europe. “Hand tracking will ultimately deliver a better experience in virtual reality for users. Rendever will be one of the first to use hand tracking in their platform. It’s great to see it being rolled out for such a good cause by helping seniors maintain an active lifestyle.”
Rendever is committed to supporting and improving seniors’ mental health and wellbeing through its platform. During the COVID-19 pandemic, RendeverLive™ was launched, a daily live-programming feature that keeps residents engaged while giving overworked staff a chance to take a break and join in the fun. This new feature was announced as one of TIME’s 2021 Best 100 Inventions.
RendeverFit™ is currently available to order for all senior living communities and healthcare organizations worldwide. To learn more, visit www.rendever.com/rendeverfit.
Rendever is overcoming social isolation through the power of virtual reality and shared experiences. From senior living communities to hospitals, their platform is being used to reduce depression and loneliness by fostering personal connections amongst populations where life has become limited. Participants in group sessions can check off bucket list items together, revisit meaningful places and share stories, stay engaged with family members, and more. Rendever is being used by high-profile senior living operators including Revera, Benchmark, and SRG, healthcare systems such as UCHealth and Cleveland Clinic, has research funded by the NIH and NIA, and has commercial partnerships with major organizations like AARP and Verizon. To learn more, please visit www.rendever.com.
Uproar PR for Rendever
The FDA has granted Rare Pediatric Disease (RPD) designation to newly listed Immix Biopharma Inc's (NASDAQ: IMMX) IMX-110 for rhabdomyosarcoma, a form of pediatric cancer. IMX-110 is currently being evaluated in Phase 1b/2a clinical trial. If IMX-110 is approved in the U.S., ImmixBio may be eligible to receive a Priority Review Voucher (PRV) from the FDA, which can be redeemed to obtain priority review for any subsequent marketing application, or maybe sold or transferred. Also See: Benzinga's F
Is Pfizer stock a buy after the FDA authorized its Covid pill regimen for emergency use? Is PFE stock a buy right now?
These are the healthcare stocks with the best value, fastest growth, and most momentum for January 2022.
Read more to see why three Fool.com contributors think COVID stocks Fulgent Genetics (NASDAQ: FLGT), NRx Pharmaceuticals (NASDAQ: NRXP), and Adaptive Biotechnologies (NASDAQ: ADPT) could double your money this year. Will this stock turn on? Patrick Bafuma (Fulgent Genetics): Entering the last wave of 2021, you may have heard that there was a run on COVID tests.
Dr. Suzanne Judd, University of Alabama at Birmingham School of Public Health Epidemiologist, joins Yahoo Finance Live to examine concerns of future COVID-19 variants, Omicron's effects on both vaccinated and unvaccinated individuals, the CDC's latest isolation guidelines, Dr. Fauci's most recent comments on the pandemic, and the current variant's mutations.
The U.S. Food and Drug Administration recently acknowledged Bristol Myers Squibb's application for deucravacitinib to treat moderate-to-severe psoriasis.
New variant thought to develop in sufferers at faster pace than original Covid strain
The CEO who played a significant role in the dramatic expansion of government-funded home and community-based care for frail seniors has stepped down from the company she built as regulatory concerns continue to mount. Maureen Hewitt resigned as chief executive of InnovAge Holding (INNV) effective January 1, the Denver-based company announced Monday. InnovAge is the largest provider in the Program of All-Inclusive Care for the Elderly (PACE), a Medicare- and Medicaid-funded service designed to meet all the healthcare needs of frail seniors while keeping them out of nursing homes.
On Dec. 14, the U.S. Food and Drug Administration (FDA) approved AbbVie's (NYSE: ABBV) Rinvoq as a treatment for adult patients with psoriatic arthritis who failed at least one other tumor necrosis factor (TNF) inhibitor. A new indication is always a positive sign for a drugmaker, especially one like AbbVie that is seeking new growth avenues. What prompted the FDA's approval of Rinvoq for its second indication?
If more Americans get vaccinated and boosted, the U.S. just might return to a semblance of normalcy by February or March, the country’s top infectious disease expert said on Sunday. Hopefully, enough people get vaccinated “to the point that when omicron comes down to a low level, we keep it down at a low level enough that it doesn’t disrupt our society, our economy, our way of life,” Dr. …
Health officials are now discussing whether to require a negative COVID-19 test to end isolation periods for people with COVID-19.
The biotech company that focuses on oncology drugs released news from a positive clinical trial regarding its lead drug.
Dr. Malathi Srinivasan with Stanford Health Care weighs in on the CDC's latest isolation guidelines for COVID-19 cases, and how to tell the difference between Omicron, the flu, and the common cold
The Omicron variant of COVID-19 is sweeping the nation, as many states and the country as a whole set records for new daily cases. "Don't be surprised if you get Omicron," The Atlantic warned earlier this month, because the variant is highly contagious—twice as contagious as the Delta variant, which itself was twice as contagious as the original strain of COVID. If you do come down with Omicron, these are the most important things to do, according to experts. Read on to find out more—and to ensu
The number of people with diabetes in the U.S. has reached epidemic proportions: 1 in 10 people are affected, and about a quarter of those are undiagnosed, according to the Centers for Disease Control and Prevention (CDC). Many diabetics live with the disease or prediabetes for years without realizing it, but early detection can be the difference between being able to manage your symptoms with diet and lifestyle changes or having to be on medication—or even worse, suffering from serious complica
The coronavirus vaccines—amazing as they are—do not offer 100% protection from COVID-19. And now we know how many people so far have gotten COVID after getting vaccinated, also known as a "breakthrough" infection—especially as Omicron is better able to evade immunity. "A breakthrough infection or a vaccine failure is when a person contracts an infection despite being vaccinated against it," Dr. Anthony Fauci explained, noting that the majority of vaccines, while doing a good job at protecting yo
Tom Brenner/ReutersFlorida Gov. Ron DeSantis (R) blamed the Biden administration for COVID-19 woes in his state while accusing other state leaders of allowing “hysteria” to reign as they encourage mitigation measures against the virus that he claimed had little basis in sound science.“In terms of Florida, you look what’s going on in other states, they’re letting hysteria drive them to doing really damaging things. We thought that people had learned,” DeSantis said during his first news conferenc
Belly fat may sound cute, but it can literally kill you. Technically known as visceral fat, belly fat lies deep within the abdomen, where it surrounds organs like the liver, intestines and pancreas. It's highly metabolically active, and that's nothing but trouble: Visceral fat secretes substances that can damage those vital organs and narrow blood vessels, raising your risk of cardiovascular disease, diabetes, liver disease and more. But you can take some easy steps to reduce visceral fat. Read
Months after recovering from SARS-CoV-2 infection, survivors have elevated levels of antibodies that can mistakenly attack their own organs and tissues, even if they had not been severely ill, according to new findings. Among 177 healthcare workers who had recovered from confirmed coronavirus infections contracted before the availability of vaccines, all had persistent autoantibodies, including ones that can cause chronic inflammation and injury of the joints, skin and nervous system. "We would not normally expect to see such a diverse array of autoantibodies elevated in these individuals or stay elevated for as long six months after full clinical recovery," said Susan Cheng of the Cedars-Sinai Smidt Heart Institute in Los Angeles.
The right medication can go a long way in taking care of everything from sleepless nights to chronic pain. In fact, they can be so helpful that it can be easy to keep using them without much thought. But due to a new recall from the Food&Drug Administration (FDA), you may want to take a moment to check if one medication in your daily routine could be affected. Read on to see which popular product is being pulled from pharmacies.RELATED: If You Use This Medication, Stop Immediately, FDA Says. Tar